Worldwide Clinical Trials is beefing up its U.S. business development operations with the additions of CRO industry experts Giovanna Chan and Cara Staley.
The two will lead the western and eastern U.S. regions, respectively, the company said.
Chan and Staley will report to Sara Davis, who joined Worldwide Clinical in June and was recently promoted to head its global commercial team.
The moves are part of the company’s plan to expand its resources to meet expected demands from small and midsize pharmaceutical and biopharma organizations from CRO partners.
“Sponsors tell us they need their CRO partner to scale to manage global development portfolios, offer deep expertise and operational excellence to challenge the status quo, and innovate to reduce the time and cost of drug development,” Davis said in a statement.
In May, Worldwide partnered with Datavant to explore the reasons clinical trials in neurodegenerative diseases fail and how big data tactics can improve prolonged study monitoring and conduct.